These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 795602)

  • 1. [The hepatorenal syndrome: etiopathogenetic, clinical and therapeutic considerations].
    Mancinella A
    Clin Ter; 1976 Dec; 79(6):583-90. PubMed ID: 795602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatorenal syndrome].
    Emmrich R
    Z Gesamte Inn Med; 1970 May; 25(9):377-80. PubMed ID: 5523524
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatorenal syndrome.
    Ficarra BJ; Altman KA
    Am J Gastroenterol; 1969 May; 51(5):442-3. PubMed ID: 5786694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatorenal syndrome (a review of the literature)].
    Makovetskaia GA; Munina LN; Soshnikova MA; Kryshkovets DV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):46-9. PubMed ID: 347708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal insufficiency in liver cirrhosis and in hepato-renal syndrome].
    D'Angelo A; Maschio G; Naccarato R
    Recenti Prog Med; 1975 Aug; 59(2):182-91. PubMed ID: 1243906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenetic aspects of cholemic nephropathy].
    Lenti G; Emanuelli G; Gatti G; Cestonaro G; Calcamuggi G; Anfossi G; Battaglia G; Camussi G; Robecchi A
    Minerva Med; 1978 Oct; 69(47):3203-14. PubMed ID: 362245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of endotoxins in renal changes during hepatopathies].
    Liehr H; Grün M
    Minerva Med; 1978 Oct; 69(47):3231-42. PubMed ID: 362247
    [No Abstract]   [Full Text] [Related]  

  • 8. Frusemide in liver diseases with renal failure.
    Borirakchanyavat V; Sitprija V
    J Med Assoc Thai; 1978 Sep; 61(9):514-20. PubMed ID: 690539
    [No Abstract]   [Full Text] [Related]  

  • 9. The hepato-renal syndrome.
    Kahn A
    J Ark Med Soc; 1970 May; 66(12):499-500. PubMed ID: 4246078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal insufficiency in liver transplantation].
    Rimola A
    Nefrologia; 2002; 22 Suppl 5():69-71. PubMed ID: 12107922
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute renal failure and hepatobiliary tract diseases].
    Ichida F; Watanabe T
    Nihon Rinsho; 1983; 41(1):82-7. PubMed ID: 6842866
    [No Abstract]   [Full Text] [Related]  

  • 12. [Organic nephropathies in patients with liver diseases].
    Amoedo ML; Montoliu J
    Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatorenal syndrome in neonates.
    Amir J; Dinari G; Zelikovic I; Wilunski E
    Helv Paediatr Acta; 1984 May; 39(2):167-9. PubMed ID: 6543840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Affection of the kidneys in chronic hepatitis and cirrhosis of the liver].
    Shulutko BI
    Klin Med (Mosk); 1971 Aug; 49(8):64-9. PubMed ID: 5127465
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on renal failure and cirrhosis, with special emphasis on functional renal failure.
    Paesano J
    J Am Osteopath Assoc; 1972 Nov; 72(3):260-4. PubMed ID: 4485541
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepato-renal syndrome.
    Br Med J; 1969 Apr; 2(5651):201-2. PubMed ID: 5780421
    [No Abstract]   [Full Text] [Related]  

  • 17. The hepatorenal syndrome.
    Papper S
    Clin Nephrol; 1975 Aug; 4(2):41-4. PubMed ID: 1098816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal changes in chronic liver diseases. I. Morphological definition and histogenetic theories].
    Frizzera G; Mancini AM; Tison V; Vecchi A
    Arch Ital Anat Istol Patol; 1968; 42(1):5-45. PubMed ID: 5742957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Percutaneous liver biopsy in a clinic for heart and vascular diseases].
    Weidemann R
    Med Klin; 1970 Apr; 65(14):656-61. PubMed ID: 5507798
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
    Zipser RD; Radvan GH; Kronborg IJ; Duke R; Little TE
    Gastroenterology; 1983 Apr; 84(4):697-703. PubMed ID: 6572162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.